BEAM - Beam Therapeutics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.00
DETAILS
HIGH:
$80.00
LOW:
$26.00
MEDIAN:
$40.00
CONSENSUS:
$48.00
UPSIDE:
67.60%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-01 | Evans John M. | director, officer: CEO | SELL | 30,078 | $24.58 | $739K |
| 2026-04-01 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | SELL | 3,242 | $24.58 | $80K |
| 2026-04-01 | Bellon Christine | officer: Chief Legal Officer | SELL | 5,956 | $24.58 | $146K |
| 2026-04-01 | Ciaramella Giuseppe | officer: President | SELL | 11,810 | $24.58 | $290K |
| 2026-04-01 | Simon Amy | officer: Chief Medical Officer | SELL | 6,700 | $24.58 | $165K |
| 2026-03-31 | Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 31,750 | -- | -- |
| 2026-03-31 | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | A-Award | 20,000 | -- | -- |
| 2026-03-31 | Bellon Christine | officer: Chief Legal Officer | A-Award | 20,000 | -- | -- |
| 2026-03-31 | Ciaramella Giuseppe | officer: President | A-Award | 40,000 | -- | -- |
| 2026-03-31 | Simon Amy | officer: Chief Medical Officer | A-Award | 31,750 | -- | -- |
| 2026-03-30 | Evans John M. | director, officer: CEO | M-Exempt | 25,000 | $0.67 | $17K |
| 2026-03-31 | Evans John M. | director, officer: CEO | M-Exempt | 25,000 | $0.67 | $17K |
| 2026-03-31 | Evans John M. | director, officer: CEO | SELL | 25,000 | $22.76 | $569K |
| 2026-03-31 | Evans John M. | director, officer: CEO | A-Award | 90,000 | -- | -- |
| 2026-03-30 | Evans John M. | director, officer: CEO | SELL | 25,000 | $22.37 | $559K |
| 2026-02-24 | Ciaramella Giuseppe | officer: President | SELL | 35,000 | $32.00 | $1.1M |
| 2026-02-24 | Ciaramella Giuseppe | officer: President | M-Exempt | 35,000 | $17.00 | $595K |
| 2026-01-31 | Ciaramella Giuseppe | officer: President | A-Award | 80,000 | $27.62 | $2.2M |
| 2026-01-30 | Evans John M. | director, officer: CEO | SELL | 22,094 | $28.27 | $625K |
| 2026-01-30 | Evans John M. | director, officer: CEO | SELL | 2,906 | $29.00 | $84K |
| 2026-01-29 | Evans John M. | director, officer: CEO | M-Exempt | 5,664 | $0.67 | $4K |
| 2026-01-29 | Evans John M. | director, officer: CEO | M-Exempt | 19,336 | $0.67 | $13K |
| 2026-01-29 | Evans John M. | director, officer: CEO | SELL | 16,333 | $29.19 | $477K |
| 2026-01-30 | Evans John M. | director, officer: CEO | M-Exempt | 25,000 | $0.67 | $17K |
| 2026-01-31 | Emany Sravan Kumar | officer: Chief Financial Officer | A-Award | 63,500 | $27.62 | $1.8M |